Trials / Completed
CompletedNCT03638427
Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 159 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood in a smart menstrual pad. In other words, can the investigators detect the high risk strains of the human papilloma virus (HPV) that are associated with cervical cancer in self-collected menstrual blood, as an alternative to collecting vaginal swabs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Menstrual Blood Analysis (Menstrual Blood Analysis) | We will be testing women's menstrual blood to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood from a menstrual pad. |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2022-10-11
- Completion
- 2022-11-30
- First posted
- 2018-08-20
- Last updated
- 2024-05-28
- Results posted
- 2024-05-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03638427. Inclusion in this directory is not an endorsement.